Real-time enrollment status for this focal epilepsy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06309966 |
| Recruiting Status | Recruiting |
| Condition | Focal Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 390 participants |
| Active Locations | 45 sites in the US |
| Sponsor | Biohaven Therapeutics Ltd. |
| Last Updated on CT.gov | February 25, 2026 (5 days ago) |
As of March 2, 2026: Clinical trial NCT06309966 is currently recruiting participants. This clinical trial study for focal epilepsy is actively seeking new participants at 45 locations across the United States. The study is sponsored by Biohaven Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06309966 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06309966 was last updated 5 days ago (February 25, 2026). HelloStudys verifies this status automatically.